use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity of antitumor drugs.

摘要

agent for prevention and control of systemic toxicity or neurotoxicity caused by the chronic administration of antineoplastic agents.that must be administered to the patient before the administration of these agents (which includes as an active ingredient a mixture of gangliosides gm1, gd1a, gt1b gd1b and.